BRPI0509878A - ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária - Google Patents
ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronáriaInfo
- Publication number
- BRPI0509878A BRPI0509878A BRPI0509878-5A BRPI0509878A BRPI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A
- Authority
- BR
- Brazil
- Prior art keywords
- depression
- patients
- prevention
- treatment
- heart disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
áCIDOS GRAXOS ESSENCIAIS NA PREVENçãO E/OU TRATAMENTO DA DEPRESSãO EM DOENTES COM DOENçA ARTERIAL OU CARDìACA CORONáRIA. A presente invenção refere-se à utilização de uma composição farmacêutica que contém ésteres etílicos de ácidos graxas essenciais originários de óleos de peixe, em particular como uma mistura de concentração elevada de ésteres etílicos de ácido eicosapentanóico (EPA) (20:5<sym>3) e ácido docosahexanóico (DHA) (22:6<sym>3) na prevenção e/ou tratamento da depressão em doentes com doença cardiovascular, tal como doença cardíaca coronária e/ou arterial coronária ou vascular.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101578 | 2004-04-16 | ||
PCT/EP2005/004031 WO2005110393A1 (en) | 2004-04-16 | 2005-04-15 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509878A true BRPI0509878A (pt) | 2007-10-16 |
Family
ID=34928968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509878-5A BRPI0509878A (pt) | 2004-04-16 | 2005-04-15 | ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1765319A1 (pt) |
JP (1) | JP2007532605A (pt) |
CN (1) | CN1942180A (pt) |
AU (1) | AU2005244483B2 (pt) |
BR (1) | BRPI0509878A (pt) |
CA (1) | CA2504280A1 (pt) |
IL (1) | IL178300A0 (pt) |
MX (1) | MX291518B (pt) |
RU (1) | RU2387448C2 (pt) |
UA (1) | UA94693C2 (pt) |
WO (1) | WO2005110393A1 (pt) |
ZA (1) | ZA200607794B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2421909A (en) * | 2004-12-23 | 2006-07-12 | Laxdale Ltd | Pharmaceutical compositions comprising EPA and methods of use |
ITMI20100961A1 (it) * | 2010-05-27 | 2011-11-28 | Erredue Spa | Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998048788A1 (en) * | 1997-04-29 | 1998-11-05 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
PT1390025E (pt) * | 2001-05-30 | 2005-08-31 | Laxdale Ltd | Utilizacao de coenzima q (ubiquinona) e acido eicosapentaenoico (epa) para o tratamento de linfoma nao de hodgkin e de distubios psiquiatricos ou neurologicos |
-
2005
- 2005-04-15 UA UAA200611798A patent/UA94693C2/ru unknown
- 2005-04-15 JP JP2007507767A patent/JP2007532605A/ja active Pending
- 2005-04-15 CA CA002504280A patent/CA2504280A1/en not_active Abandoned
- 2005-04-15 MX MXPA06011940 patent/MX291518B/es active IP Right Grant
- 2005-04-15 ZA ZA200607794A patent/ZA200607794B/en unknown
- 2005-04-15 WO PCT/EP2005/004031 patent/WO2005110393A1/en active Application Filing
- 2005-04-15 AU AU2005244483A patent/AU2005244483B2/en not_active Ceased
- 2005-04-15 EP EP05779398A patent/EP1765319A1/en not_active Withdrawn
- 2005-04-15 BR BRPI0509878-5A patent/BRPI0509878A/pt not_active IP Right Cessation
- 2005-04-15 RU RU2006140277/14A patent/RU2387448C2/ru not_active IP Right Cessation
- 2005-04-15 CN CNA2005800114285A patent/CN1942180A/zh active Pending
-
2006
- 2006-09-26 IL IL178300A patent/IL178300A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1942180A (zh) | 2007-04-04 |
AU2005244483B2 (en) | 2011-06-09 |
AU2005244483A1 (en) | 2005-11-24 |
EP1765319A1 (en) | 2007-03-28 |
WO2005110393A1 (en) | 2005-11-24 |
IL178300A0 (en) | 2007-02-11 |
UA94693C2 (ru) | 2011-06-10 |
MXPA06011940A (es) | 2006-12-15 |
ZA200607794B (en) | 2008-05-28 |
CA2504280A1 (en) | 2005-10-16 |
RU2387448C2 (ru) | 2010-04-27 |
MX291518B (es) | 2011-10-31 |
RU2006140277A (ru) | 2008-05-27 |
JP2007532605A (ja) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303019A2 (hu) | Esszenciális N-3 zsírsavakat tartalmazó gyógyszerkészítmények alkalmazása a szívgyengeség és szívelégtelenség terápiájában | |
Singer et al. | Slow desaturation and elongation of linoleic and α-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects | |
Billman et al. | Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs | |
Wiktorowska-Owczarek et al. | PUFAs: structures, metabolism and functions | |
Horrobin et al. | Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding | |
BRPI0408006A (pt) | uso de ácidos graxos Èmega -3 no tratamento de pacientes diabéticos | |
US20080113046A1 (en) | Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients | |
DE60000133C5 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
WO2008018043A3 (en) | Methods of improving bone health and muscle health | |
TR201908522T4 (tr) | Kan lipidi düşürücü maddeler olarak keton gövdeleri ve keton gövde esterleri. | |
BRPI0518398A2 (pt) | Ácidos graxos âmega-3 e agente deslipidÊmico para terapia de lipÍdeos | |
WO2009091538A3 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
CO6470839A2 (es) | Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas | |
WO2007103160A3 (en) | Stearidonic acid for improving cardiovascular health | |
JPS60115522A (ja) | 血中のコレステロ−ル及びトリグリセリドのレベルを低下させるための複合脂肪酸組成物 | |
Shahidi | Omega-3 fatty acids and marine oils in cardiovascular and general health: A critical overview of controversies and realities | |
MA30584B1 (fr) | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires | |
NO20076382L (no) | Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer | |
JP2008050367A5 (pt) | ||
WO2003072111A3 (en) | Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression | |
RU2008103281A (ru) | Способы и композиции для профилактики и лечения воспалительного заболевания | |
Kaur et al. | Synthesis and functional significance of poly unsaturated fatty acids (PUFA’s) in body | |
BRPI0509878A (pt) | ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária | |
ATE424732T1 (de) | Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate | |
US20100239660A1 (en) | Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: ABBOTT PRODUCTS GMBH (DE) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015. |